Company intelligence / Profile preview

Helix Technologies

Knoxville, Tennessee, United States

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Helix Biotech operates as a contract development and manufacturing organization (CDMO) specializing in design, formulation, and GMP manufacturing of nucleic acids (particularly mRNA), lipid nanoparticles (LNPs), liposomes, and related nanoparticle systems for pharmaceutical and biotech clients, supporting projects from early-stage R&D through clinical translation and commercial scale-up.[5][6][7][8][9]

Modalities: mRNA-based drugsDNASmall moleculeProteinNanoparticle
Industry: Contract Manufacturing Organization

Partnerships

Multiple emerging biotech and established pharmaceutical companies as CDMO clients (not individually named)[7][8][9]

Beyond the preview

Go deeper on Helix Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helix Technologies.

Explore the full profile